title: CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation.
abstract: Hypercholesterolemia is associated with phenotypic changes in endothelial cell function that lead to a proinflammatory and prothrombogenic state in different segments of the microvasculature. CD40 ligand (CD40L) and its receptor CD40 are ubiquitously expressed and mediate inflammatory responses and platelet activation. The objective of this study was to determine whether CD40/CD40L, in particular T-cell CD40L, contributes to microvascular dysfunction induced by hypercholesterolemia. Intravital microscopy was used to quantify blood cell adhesion in cremasteric postcapillary venules, endothelium-dependent vasodilation responses in arterioles, and microvascular oxidative stress in wild-type (WT) C57BL/6, CD40-deficient ((-/-)), CD40L(-/-), or severe combined immune deficient (SCID) mice placed on a normal (ND) or high-cholesterol (HC) diet for 2 wk. WT-HC mice exhibited an exaggerated leukocyte and platelet recruitment in venules and impaired vasodilation responses in arterioles compared with ND counterparts. A deficiency of CD40, CD40L, or lymphocytes attenuated these responses to HC. The HC phenotype was rescued in CD40L(-/-) and SCID mice by a transfer of WT T cells. Bone marrow chimeras revealed roles for both vascular- and blood cell-derived CD40 and CD40L in the HC-induced vascular responses. Hypercholesterolemia induced an oxidative stress in both arterioles and venules of WT mice, which was abrogated by either CD40 or CD40L deficiency. The transfer of WT T cells into CD40L(-/-) mice restored the oxidative stress. These results implicate CD40/CD40L interactions between circulating cells and the vascular wall in both the arteriolar and venular dysfunction elicited by hypercholesterolemia and identify T-cell-associated CD40L as a key mediator of these responses.
authors.affiliation: Dept. of Molecular and Cellular Physiology, LSU Health Sciences Ctr., 1501 E. Kings Hwy., Shreveport, LA 71130-3932, USA.
authors.forename: Karen Y
authors.initials: KY
authors.lastname: Stokes
authors.forename: Leshanna
authors.initials: L
authors.lastname: Calahan
authors.forename: Candiss M
authors.initials: CM
authors.lastname: Hamric
authors.forename: Janice M
authors.initials: JM
authors.lastname: Russell
authors.forename: D Neil
authors.initials: DN
authors.lastname: Granger
mesh_terms: D019264:Adoptive Transfer; D000818:Animals; D001160:Arterioles / Q000276:immunology; D001792:Blood Platelets / Q000276:immunology; D016026:Bone Marrow Transplantation; D019013:CD40 Antigens / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D023201:CD40 Ligand / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D002448:Cell Adhesion; D016207:Cytokines / Q000097:blood; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000276:immunology; D006937:Hypercholesterolemia / Q000150:complications / Q000276:immunology* / Q000503:physiopathology; D007249:Inflammation / Q000276:immunology* / Q000503:physiopathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D016513:Mice, SCID; D008833:Microcirculation; D018482:Muscle, Skeletal / Q000098:blood supply*; D018384:Oxidative Stress; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology* / Q000637:transplantation; D018183:Transplantation Chimera / Q000276:immunology; D014664:Vasodilation; D014699:Venules / Q000276:immunology
chemical_list: D019013:CD40 Antigens; D016207:Cytokines; D023201:CD40 Ligand